This is a multicenter, open-label, prospective Phase 1/2a study to assess safety and tolerability, establish dosimetry and to identify an optimal imaging dose …

Metastatic SarcomaEsophageal CancerGastric Cancer+3 more

~Estimated

~$10 – $8,750

Lantheus Medical ImagingNCT06298916

Phase 2

A Phase 2 Study of RP2 With Tivozanib in Patients With Metastatic Renal Carcinoma After Progression to Immunotherapy

This phase II trial tests the effect of RP2 and tivozanib in treating patients with renal cell cancer that has spread from where it first started (primary site…

Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more

~Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07218692

← PreviousPage 2 of 2Next →